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postcondioning cycles at onset of reperfusion and 1153 patients to
usual percutaneous coronary intervention (PCI). Statistical analysis
indicated that the peak of creatine kinase (CK) and creatine kinase
isoenzyme (CKMB) in postconditioning (PoC) groups decrease signif-
icantly during the ﬁrst 72 hours after PCI compared with controls
(Con) (P<0.001 & P<0.05). The data showed smaller infarct size (IS) in
PoCþ PCI than in PCI patients during7 days after myocardial infarc-
tion (p¼0.01). However, IS was not signiﬁcantly different between
study groups after4-6 months (p¼0.08). While there was a trend to-
ward reduction of IS. LVEF is also improved during 7days after
myocardial infarction (p<0.001). LVEF was also improved 4-12months
after myocardial infarction (p¼0.02).
CONCLUSIONS Ischemic postconditioning by brief interruptions of
coronary blood ﬂow at the onset of reperfusion after PCI appears to be
superior to PCI alone in reduction of both myocardial injury and left
ventricular function. Ischemic postconditioning attenuated CK
release and reduced infarct size for up to 7 days after reperfusion in
patients with STEMI, but seems failing to limit IS for long time.
However, long-term LVEF may be improved by the additional
protocol.GW26-e4027
Effect of candesartan on proliferation of vascular smooth muscle cell
induced by high glucose
Shaojing Xi, Liguo Lang, Yunlu Li, Lijun Ge
Ningxia People’s Hospital
OBJECTIVES To observe the rat vascular smooth muscle cell A7r5
proliferation at high concentrations of glucose, as well as changes in
the secretion of candesartan (Cand) the effect of different
concentrations.
METHODS A7r5 cell culture 48h after randomization, normal glucose
group (NG, 5 mM D-glucose), high glucose (HG, 15, 25, 35, 45 mM
D-glucose), high glucose (25mM) þ Cand10- 5mol / L group, high
glucose (25mM) þ Cand10-6mol / L group, high glucose (25mM) þ
Cand10-7mol / L group, cell proliferation assay by MTT; ELISA detect
AngII levels; using immunoﬂuorescence staining to detect AT1 re-
ceptor on cell membrane of A7r5.
RESULTS (1) after culture 24, 48, 72h, compared with NG group, HG
group absorbance values were signiﬁcantly higher (p <0.05) and the
highest one is 25mM group(p <0.01); (2) after culture 48h, compared
with the NG group, HG group AngII secretion was signiﬁcantly
increased (P <0.05) and the highest one is 25mM group (p <0.01); (3)
immunoﬂuorescence staining observed A7r5 AT1 receptor on cell
membrane, and the HG group is signiﬁcantly increased the amount of
the distribution compared NG group; (4) compared to the 25mM
group, in high concentrations Cand group inhibit A7r5 cell prolifera-
tion, and the differences were statistically signiﬁcant (p <0.05); (5)
compared with high glucose 25mM group, Cand group do not affect
the secretion of AngII, the difference was not statistically sig-
niﬁcant(P>0.05); (6) compared with high glucose 25mM group, Cand
group AT1 receptor on the cell membrane signiﬁcantly reduced the
amount of the distribution.
CONCLUSIONS High glucose can induce abnormal cell proliferation,
prompting cells to secrete AngII, prompting an increase in AT1 re-
ceptor on the cell membrane distribution volume. Cand may antago-
nize AngII with AT1 receptor binding, and play high glucose-induced
inhibition of A7r5 cell proliferation.
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Is The Beneﬁts Of Enhanced External Counter Pulsation In Patient With
Moderate Left Ventricular Dysfunction Independent of Diabetes?
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OBJECTIVES Enhanced External Counter Pulsation (EECP) is a non-
invasive treatment option for selected patients with refractory
angina and heart failure. The effectiveness of EECP in improving
myocardial function in diabetic patients when compared to non
diabetic is unknown. We tested the hypothesis whether the effect
of EECP in Left ventricular function is independent of diabetic
status.METHODS We investigate the effect of EECP in a group of 63
consecutive patients with left ventricular dysfunction (EF40%).
They are divided in to Diabetes (DM, 36) and Non-Diabetic
(NDM, 27) groups, Functional classiﬁcation and Echocardiography
by simpson rule was done pre and post 35 hours of EECP
treatment.
RESULTS There is no signiﬁcant difference between Diabetes Mellitus
(DM) and NDM in Patients mean age (61.333 10.62 Vs 59.89  10.03
years, P¼ NS), HT 56% Vs 56% (P¼ NS), previous history of CABG (39%
Vs 41%, P¼ NS) and PTCA (19% Vs 26%, P¼ NS). However NDM has
signiﬁcantly higher incidence of Myocardial infarction. (41% Vs 77%,
P<0.0001)
The improvement of parameters when compared pre and post EECP
between DM vs. NDM, NYHA class improvement ( 2.70.6 to 1.1  0.8 )
P<0.001 Vs ( 2.90.7 to 1.3  0.8) P < 0.001, Ejection fraction in %
(29.87.9 to 36.28.6) P< 0.001 Vs ( 29.98.5 to 35.9 10.5) P < 0.001,
cardiac output in ml/min (3.1  0.7 to 3.91.0) P < 0.001 Vs ( 3.30.7 to
4.1  0.7) P< 0.001 and stroke volume in ml (48.318.9 to 54.817.7)
P< 0.05 Vs (46.7  16.4 to 55.716.8) P < 0.001. All parameters show
signiﬁcant improvement when compared with pre and post EECP in
both the groups but there is no signiﬁcant difference in improvement
between DM and NDM.
CONCLUSIONS EECP treatment signiﬁcantly reduces NYHA func-
tional class, increase ejection fraction, cardiac output and stroke
volume in both diabetes and non diabetes patients with refractory
angina and Left ventricular dysfunction similarly. The effect of EECP
seems to be independent on the status of diabetes.GW26-e4530
Correlation between LDL-C, BMI and Coronary Slow Flow
Ye Zhou, Muyang Yan
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OBJECTIVES The aim of this research is to study correlation between
LDL-C, BMI and coronary slow ﬂow phenomenon (CSFP).
METHODS The 150 patients with chest pain, who were underwent
coronary angiography were divided by corrected TIMI frame count
(CSFP was deﬁned as frame count >27) into CSF group (79) and control
group (71). Body mass index (BMI), age, gender, history of smoking,
hypertension, diabetes and hyperlipidemia were recorded and the
total cholesterol (TC), triglyceride (TG), Low-density lipoprotein
(LDL-C), high-density lipoprotein (HDL-C), uric acid (UA), creatinine
(Cr), left ventricular ejection fraction (EF), systolic blood pressure
(SBP) and diastolic blood pressure (DBP) were measured on
admission.
RESULTS The smoking rate, BMI, TG, LDL-C, UA were signiﬁcantly
higher in the patients with the CSF group than the subjects in control
group. BMI, LDL-C in the CSF group increased signiﬁcantly with
increasing vessel involvement. The logistic regression analysis
showed that BMI and LDL-C were the inﬂuence factor for coronary
slow ﬂow, and were positively correlated with CSFP.
CONCLUSIONS CSFP (coronary slow ﬂow phenomenon) is associated
with BMI and LDL-C.GW26-e5434
The study of relationships between intra-abdominal obesity and high
sensitive C-reactive protein, tissue inhibitor of metalloproteinase-1 in
patients with coronary heart disease
Xingshan Zhao, Jihong Wang, Jinjin Zhai, Yonghao Lan, Mei Zheng,
Xiaoguang Cheng
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OBJECTIVES The aim of this study is to investigate the relation be-
tween intra-abdominal obesity and the serum levels of inﬂammatory
factors - high sensitive C-reactive protein (hs-CRP) and tissue inhibi-
tor of metalloproteinase-1 (TIMP-1) in patients with coronary heart
disease (CHD).
METHODS A total of 85 persons were divided into two groups of
disease group and control group. All subjects were observed to survey
the height, body weight, waist circumference (WC), then calculated
the body mass index (BMI) and the waist-to-hip ratio (WHR). All
subjects were evaluated with a DEXA total body scan performed using
a Lunar Prodigy system(GE Healthcare). All subjects were collected
venous blood to assay fasting total cholesterol (TC), triglyceride(TG),
